nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluphenazine—ABCB1—peripheral nervous system neoplasm	0.325	1	CbGaD
Fluphenazine—CYP2E1—Dacarbazine—peripheral nervous system neoplasm	0.0552	0.17	CbGbCtD
Fluphenazine—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0399	0.123	CbGbCtD
Fluphenazine—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0349	0.108	CbGbCtD
Fluphenazine—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0349	0.108	CbGbCtD
Fluphenazine—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0319	0.0984	CbGbCtD
Fluphenazine—CYP2E1—Etoposide—peripheral nervous system neoplasm	0.027	0.0833	CbGbCtD
Fluphenazine—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0242	0.0746	CbGbCtD
Fluphenazine—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0156	0.0482	CbGbCtD
Fluphenazine—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0149	0.046	CbGbCtD
Fluphenazine—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0139	0.0429	CbGbCtD
Fluphenazine—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0136	0.0421	CbGbCtD
Fluphenazine—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00931	0.0287	CbGbCtD
Fluphenazine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00877	0.0271	CbGbCtD
Fluphenazine—HTR2A—phrenic nerve—peripheral nervous system neoplasm	0.00782	0.109	CbGeAlD
Fluphenazine—CALM1—trigeminal nerve—peripheral nervous system neoplasm	0.00469	0.0655	CbGeAlD
Fluphenazine—HTR6—ganglion—peripheral nervous system neoplasm	0.00356	0.0497	CbGeAlD
Fluphenazine—CALM1—cranial nerve—peripheral nervous system neoplasm	0.00334	0.0467	CbGeAlD
Fluphenazine—CALM2—pons—peripheral nervous system neoplasm	0.00332	0.0463	CbGeAlD
Fluphenazine—CALM1—pons—peripheral nervous system neoplasm	0.0033	0.0461	CbGeAlD
Fluphenazine—HTR2A—trigeminal nerve—peripheral nervous system neoplasm	0.00286	0.0399	CbGeAlD
Fluphenazine—DRD1—nerve—peripheral nervous system neoplasm	0.00268	0.0374	CbGeAlD
Fluphenazine—HTR2A—vagus nerve—peripheral nervous system neoplasm	0.00267	0.0373	CbGeAlD
Fluphenazine—DRD1—ganglion—peripheral nervous system neoplasm	0.00265	0.0369	CbGeAlD
Fluphenazine—HTR2C—ganglion—peripheral nervous system neoplasm	0.00205	0.0287	CbGeAlD
Fluphenazine—HTR2A—cranial nerve—peripheral nervous system neoplasm	0.00204	0.0284	CbGeAlD
Fluphenazine—HTR2A—pons—peripheral nervous system neoplasm	0.00201	0.0281	CbGeAlD
Fluphenazine—HTR1A—ganglion—peripheral nervous system neoplasm	0.00173	0.0242	CbGeAlD
Fluphenazine—CALM2—nerve—peripheral nervous system neoplasm	0.00172	0.024	CbGeAlD
Fluphenazine—CALM1—nerve—peripheral nervous system neoplasm	0.00171	0.0239	CbGeAlD
Fluphenazine—CALM2—ganglion—peripheral nervous system neoplasm	0.0017	0.0237	CbGeAlD
Fluphenazine—CALM1—ganglion—peripheral nervous system neoplasm	0.00169	0.0236	CbGeAlD
Fluphenazine—DRD2—nerve—peripheral nervous system neoplasm	0.00158	0.0221	CbGeAlD
Fluphenazine—DRD2—ganglion—peripheral nervous system neoplasm	0.00156	0.0218	CbGeAlD
Fluphenazine—DRD1—brainstem—peripheral nervous system neoplasm	0.00115	0.0161	CbGeAlD
Fluphenazine—CALM3—trigeminal ganglion—peripheral nervous system neoplasm	0.00106	0.0148	CbGeAlD
Fluphenazine—HTR2A—nerve—peripheral nervous system neoplasm	0.00104	0.0146	CbGeAlD
Fluphenazine—HTR2A—ganglion—peripheral nervous system neoplasm	0.00103	0.0144	CbGeAlD
Fluphenazine—CALM3—parotid gland—peripheral nervous system neoplasm	0.001	0.014	CbGeAlD
Fluphenazine—HTR2C—brainstem—peripheral nervous system neoplasm	0.000893	0.0125	CbGeAlD
Fluphenazine—CALM2—trigeminal ganglion—peripheral nervous system neoplasm	0.000835	0.0117	CbGeAlD
Fluphenazine—CALM1—trigeminal ganglion—peripheral nervous system neoplasm	0.000831	0.0116	CbGeAlD
Fluphenazine—CALM2—parotid gland—peripheral nervous system neoplasm	0.000788	0.011	CbGeAlD
Fluphenazine—HTR1A—brainstem—peripheral nervous system neoplasm	0.000752	0.0105	CbGeAlD
Fluphenazine—CALM2—brainstem—peripheral nervous system neoplasm	0.000739	0.0103	CbGeAlD
Fluphenazine—CALM1—brainstem—peripheral nervous system neoplasm	0.000736	0.0103	CbGeAlD
Fluphenazine—DRD2—brainstem—peripheral nervous system neoplasm	0.000679	0.00949	CbGeAlD
Fluphenazine—HRH1—trigeminal ganglion—peripheral nervous system neoplasm	0.000606	0.00847	CbGeAlD
Fluphenazine—ADRA2A—trigeminal ganglion—peripheral nervous system neoplasm	0.000595	0.00832	CbGeAlD
Fluphenazine—Dysphagia—Dactinomycin—peripheral nervous system neoplasm	0.000582	0.00314	CcSEcCtD
Fluphenazine—Renal failure acute—Cisplatin—peripheral nervous system neoplasm	0.000576	0.00311	CcSEcCtD
Fluphenazine—Cardiac arrest—Vincristine—peripheral nervous system neoplasm	0.000572	0.00308	CcSEcCtD
Fluphenazine—Oedema peripheral—Isotretinoin—peripheral nervous system neoplasm	0.000562	0.00303	CcSEcCtD
Fluphenazine—Oedema peripheral—Tretinoin—peripheral nervous system neoplasm	0.000562	0.00303	CcSEcCtD
Fluphenazine—Pancytopenia—Dactinomycin—peripheral nervous system neoplasm	0.000553	0.00298	CcSEcCtD
Fluphenazine—Seborrhoeic dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000552	0.00298	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Cisplatin—peripheral nervous system neoplasm	0.00055	0.00296	CcSEcCtD
Fluphenazine—Triflupromazine—BCHE—peripheral nervous system neoplasm	0.000545	0.248	CrCbGaD
Fluphenazine—Asthma—Alitretinoin—peripheral nervous system neoplasm	0.00054	0.00291	CcSEcCtD
Fluphenazine—Dysphagia—Alitretinoin—peripheral nervous system neoplasm	0.00054	0.00291	CcSEcCtD
Fluphenazine—Pneumonia—Dactinomycin—peripheral nervous system neoplasm	0.000522	0.00281	CcSEcCtD
Fluphenazine—Seborrhoeic dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000511	0.00275	CcSEcCtD
Fluphenazine—Dermatitis atopic—Epirubicin—peripheral nervous system neoplasm	0.000509	0.00274	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Etoposide—peripheral nervous system neoplasm	0.000504	0.00272	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Alitretinoin—peripheral nervous system neoplasm	0.000502	0.0027	CcSEcCtD
Fluphenazine—Erythema—Isotretinoin—peripheral nervous system neoplasm	0.000496	0.00268	CcSEcCtD
Fluphenazine—Erythema—Tretinoin—peripheral nervous system neoplasm	0.000496	0.00268	CcSEcCtD
Fluphenazine—Pancytopenia—Vincristine—peripheral nervous system neoplasm	0.000494	0.00266	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Alitretinoin—peripheral nervous system neoplasm	0.000493	0.00266	CcSEcCtD
Fluphenazine—Agranulocytosis—Dactinomycin—peripheral nervous system neoplasm	0.000484	0.00261	CcSEcCtD
Fluphenazine—Pneumonia—Alitretinoin—peripheral nervous system neoplasm	0.000484	0.00261	CcSEcCtD
Fluphenazine—Drowsiness—Alitretinoin—peripheral nervous system neoplasm	0.000481	0.00259	CcSEcCtD
Fluphenazine—Muscle spasms—Topotecan—peripheral nervous system neoplasm	0.000481	0.00259	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Vincristine—peripheral nervous system neoplasm	0.000475	0.00256	CcSEcCtD
Fluphenazine—Dermatitis atopic—Doxorubicin—peripheral nervous system neoplasm	0.000471	0.00254	CcSEcCtD
Fluphenazine—Vision blurred—Tretinoin—peripheral nervous system neoplasm	0.000468	0.00252	CcSEcCtD
Fluphenazine—Vision blurred—Isotretinoin—peripheral nervous system neoplasm	0.000468	0.00252	CcSEcCtD
Fluphenazine—Pneumonia—Vincristine—peripheral nervous system neoplasm	0.000466	0.00251	CcSEcCtD
Fluphenazine—CALM3—cerebellum—peripheral nervous system neoplasm	0.000464	0.00648	CbGeAlD
Fluphenazine—Cardiac arrest—Etoposide—peripheral nervous system neoplasm	0.000463	0.0025	CcSEcCtD
Fluphenazine—Angioedema—Topotecan—peripheral nervous system neoplasm	0.000457	0.00246	CcSEcCtD
Fluphenazine—Agitation—Isotretinoin—peripheral nervous system neoplasm	0.000456	0.00246	CcSEcCtD
Fluphenazine—Agitation—Tretinoin—peripheral nervous system neoplasm	0.000456	0.00246	CcSEcCtD
Fluphenazine—Blood disorder—Epirubicin—peripheral nervous system neoplasm	0.000451	0.00243	CcSEcCtD
Fluphenazine—Agranulocytosis—Alitretinoin—peripheral nervous system neoplasm	0.000449	0.00242	CcSEcCtD
Fluphenazine—HTR2A—brainstem—peripheral nervous system neoplasm	0.000448	0.00626	CbGeAlD
Fluphenazine—Leukopenia—Topotecan—peripheral nervous system neoplasm	0.000448	0.00241	CcSEcCtD
Fluphenazine—Liver injury—Epirubicin—peripheral nervous system neoplasm	0.000447	0.00241	CcSEcCtD
Fluphenazine—Leukopenia—Melphalan—peripheral nervous system neoplasm	0.000438	0.00236	CcSEcCtD
Fluphenazine—Pancytopenia—Cisplatin—peripheral nervous system neoplasm	0.000437	0.00235	CcSEcCtD
Fluphenazine—Hypertension—Isotretinoin—peripheral nervous system neoplasm	0.000428	0.00231	CcSEcCtD
Fluphenazine—Hypertension—Tretinoin—peripheral nervous system neoplasm	0.000428	0.00231	CcSEcCtD
Fluphenazine—Jaundice cholestatic—Epirubicin—peripheral nervous system neoplasm	0.000428	0.00231	CcSEcCtD
Fluphenazine—Oedema peripheral—Alitretinoin—peripheral nervous system neoplasm	0.000426	0.00229	CcSEcCtD
Fluphenazine—Dysphagia—Etoposide—peripheral nervous system neoplasm	0.000421	0.00227	CcSEcCtD
Fluphenazine—Blood disorder—Doxorubicin—peripheral nervous system neoplasm	0.000417	0.00225	CcSEcCtD
Fluphenazine—Liver injury—Doxorubicin—peripheral nervous system neoplasm	0.000414	0.00223	CcSEcCtD
Fluphenazine—Dry mouth—Tretinoin—peripheral nervous system neoplasm	0.000413	0.00223	CcSEcCtD
Fluphenazine—Dry mouth—Isotretinoin—peripheral nervous system neoplasm	0.000413	0.00223	CcSEcCtD
Fluphenazine—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.000408	0.0022	CcSEcCtD
Fluphenazine—CYP2D6—brainstem—peripheral nervous system neoplasm	0.000408	0.0057	CbGeAlD
Fluphenazine—Erythema—Dactinomycin—peripheral nervous system neoplasm	0.000406	0.00219	CcSEcCtD
Fluphenazine—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.000405	0.00218	CcSEcCtD
Fluphenazine—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.000405	0.00218	CcSEcCtD
Fluphenazine—Dyskinesia—Epirubicin—peripheral nervous system neoplasm	0.0004	0.00216	CcSEcCtD
Fluphenazine—Pancytopenia—Etoposide—peripheral nervous system neoplasm	0.0004	0.00216	CcSEcCtD
Fluphenazine—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.0004	0.00216	CcSEcCtD
Fluphenazine—Skin disorder—Topotecan—peripheral nervous system neoplasm	0.000397	0.00214	CcSEcCtD
Fluphenazine—Jaundice cholestatic—Doxorubicin—peripheral nervous system neoplasm	0.000396	0.00214	CcSEcCtD
Fluphenazine—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.000395	0.00213	CcSEcCtD
Fluphenazine—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.000395	0.00213	CcSEcCtD
Fluphenazine—Skin disorder—Isotretinoin—peripheral nervous system neoplasm	0.000393	0.00212	CcSEcCtD
Fluphenazine—Skin disorder—Tretinoin—peripheral nervous system neoplasm	0.000393	0.00212	CcSEcCtD
Fluphenazine—Flupentixol—ABCB1—peripheral nervous system neoplasm	0.000392	0.178	CrCbGaD
Fluphenazine—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.00039	0.0021	CcSEcCtD
Fluphenazine—Skin disorder—Melphalan—peripheral nervous system neoplasm	0.000388	0.00209	CcSEcCtD
Fluphenazine—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.000378	0.00204	CcSEcCtD
Fluphenazine—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.000378	0.00204	CcSEcCtD
Fluphenazine—Pneumonia—Etoposide—peripheral nervous system neoplasm	0.000378	0.00204	CcSEcCtD
Fluphenazine—Hepatocellular injury—Epirubicin—peripheral nervous system neoplasm	0.000376	0.00203	CcSEcCtD
Fluphenazine—Erythema—Alitretinoin—peripheral nervous system neoplasm	0.000376	0.00203	CcSEcCtD
Fluphenazine—Hypotension—Melphalan—peripheral nervous system neoplasm	0.000374	0.00201	CcSEcCtD
Fluphenazine—Abnormal dreams—Epirubicin—peripheral nervous system neoplasm	0.000372	0.00201	CcSEcCtD
Fluphenazine—HTR1A—cerebellum—peripheral nervous system neoplasm	0.000371	0.00518	CbGeAlD
Fluphenazine—Dyskinesia—Doxorubicin—peripheral nervous system neoplasm	0.000371	0.002	CcSEcCtD
Fluphenazine—Salivary hypersecretion—Epirubicin—peripheral nervous system neoplasm	0.000366	0.00197	CcSEcCtD
Fluphenazine—CALM2—cerebellum—peripheral nervous system neoplasm	0.000364	0.00509	CbGeAlD
Fluphenazine—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.000364	0.00196	CcSEcCtD
Fluphenazine—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.000363	0.00196	CcSEcCtD
Fluphenazine—CALM1—cerebellum—peripheral nervous system neoplasm	0.000363	0.00506	CbGeAlD
Fluphenazine—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.000361	0.00195	CcSEcCtD
Fluphenazine—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.000361	0.00195	CcSEcCtD
Fluphenazine—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.00036	0.00194	CcSEcCtD
Fluphenazine—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.00036	0.00194	CcSEcCtD
Fluphenazine—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.000356	0.00192	CcSEcCtD
Fluphenazine—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.000355	0.00191	CcSEcCtD
Fluphenazine—Vision blurred—Alitretinoin—peripheral nervous system neoplasm	0.000354	0.00191	CcSEcCtD
Fluphenazine—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.000352	0.0019	CcSEcCtD
Fluphenazine—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.000352	0.0019	CcSEcCtD
Fluphenazine—Agranulocytosis—Etoposide—peripheral nervous system neoplasm	0.000351	0.00189	CcSEcCtD
Fluphenazine—Constipation—Topotecan—peripheral nervous system neoplasm	0.000349	0.00188	CcSEcCtD
Fluphenazine—Hepatocellular injury—Doxorubicin—peripheral nervous system neoplasm	0.000348	0.00188	CcSEcCtD
Fluphenazine—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.000347	0.00187	CcSEcCtD
Fluphenazine—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.000346	0.00187	CcSEcCtD
Fluphenazine—Constipation—Tretinoin—peripheral nervous system neoplasm	0.000346	0.00187	CcSEcCtD
Fluphenazine—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.000346	0.00186	CcSEcCtD
Fluphenazine—Abnormal dreams—Doxorubicin—peripheral nervous system neoplasm	0.000344	0.00186	CcSEcCtD
Fluphenazine—Salivary hypersecretion—Doxorubicin—peripheral nervous system neoplasm	0.000338	0.00182	CcSEcCtD
Fluphenazine—DRD2—cerebellum—peripheral nervous system neoplasm	0.000335	0.00468	CbGeAlD
Fluphenazine—Agitation—Vincristine—peripheral nervous system neoplasm	0.000333	0.0018	CcSEcCtD
Fluphenazine—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	0.000332	0.00463	CbGeAlD
Fluphenazine—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.000325	0.00175	CcSEcCtD
Fluphenazine—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.000324	0.00175	CcSEcCtD
Fluphenazine—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000324	0.00175	CcSEcCtD
Fluphenazine—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.000323	0.00174	CcSEcCtD
Fluphenazine—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.000322	0.00173	CcSEcCtD
Fluphenazine—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.000322	0.00173	CcSEcCtD
Fluphenazine—Erythema—Cisplatin—peripheral nervous system neoplasm	0.00032	0.00173	CcSEcCtD
Fluphenazine—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00032	0.00173	CcSEcCtD
Fluphenazine—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00032	0.00173	CcSEcCtD
Fluphenazine—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000318	0.00171	CcSEcCtD
Fluphenazine—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.000313	0.00169	CcSEcCtD
Fluphenazine—Hypertension—Vincristine—peripheral nervous system neoplasm	0.000313	0.00169	CcSEcCtD
Fluphenazine—Photosensitivity—Epirubicin—peripheral nervous system neoplasm	0.000311	0.00168	CcSEcCtD
Fluphenazine—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.000308	0.00166	CcSEcCtD
Fluphenazine—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.000307	0.00165	CcSEcCtD
Fluphenazine—Eczema—Epirubicin—peripheral nervous system neoplasm	0.000304	0.00164	CcSEcCtD
Fluphenazine—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.000302	0.00163	CcSEcCtD
Fluphenazine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000301	0.00162	CcSEcCtD
Fluphenazine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.0003	0.00162	CcSEcCtD
Fluphenazine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000298	0.00161	CcSEcCtD
Fluphenazine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000298	0.00161	CcSEcCtD
Fluphenazine—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000298	0.00161	CcSEcCtD
Fluphenazine—Renal failure acute—Epirubicin—peripheral nervous system neoplasm	0.000296	0.0016	CcSEcCtD
Fluphenazine—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.000296	0.00159	CcSEcCtD
Fluphenazine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000294	0.00159	CcSEcCtD
Fluphenazine—Dermatitis exfoliative—Epirubicin—peripheral nervous system neoplasm	0.00029	0.00156	CcSEcCtD
Fluphenazine—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000289	0.00156	CcSEcCtD
Fluphenazine—Photosensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000288	0.00155	CcSEcCtD
Fluphenazine—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000288	0.00155	CcSEcCtD
Fluphenazine—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.000287	0.00155	CcSEcCtD
Fluphenazine—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000287	0.00155	CcSEcCtD
Fluphenazine—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000287	0.00154	CcSEcCtD
Fluphenazine—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000287	0.00154	CcSEcCtD
Fluphenazine—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000283	0.00152	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Epirubicin—peripheral nervous system neoplasm	0.000282	0.00152	CcSEcCtD
Fluphenazine—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.000282	0.00152	CcSEcCtD
Fluphenazine—Eczema—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.00152	CcSEcCtD
Fluphenazine—Lethargy—Epirubicin—peripheral nervous system neoplasm	0.000279	0.0015	CcSEcCtD
Fluphenazine—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000276	0.00149	CcSEcCtD
Fluphenazine—Renal failure acute—Doxorubicin—peripheral nervous system neoplasm	0.000274	0.00148	CcSEcCtD
Fluphenazine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000274	0.00148	CcSEcCtD
Fluphenazine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000273	0.00147	CcSEcCtD
Fluphenazine—Dermatitis exfoliative—Doxorubicin—peripheral nervous system neoplasm	0.000268	0.00144	CcSEcCtD
Fluphenazine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000267	0.00144	CcSEcCtD
Fluphenazine—Chlorpromazine—BCHE—peripheral nervous system neoplasm	0.000263	0.12	CrCbGaD
Fluphenazine—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000263	0.00142	CcSEcCtD
Fluphenazine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000262	0.00142	CcSEcCtD
Fluphenazine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000262	0.00141	CcSEcCtD
Fluphenazine—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000261	0.00141	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.000261	0.00141	CcSEcCtD
Fluphenazine—ADRA2A—cerebellum—peripheral nervous system neoplasm	0.00026	0.00363	CbGeAlD
Fluphenazine—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.00026	0.0014	CcSEcCtD
Fluphenazine—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.000258	0.00139	CcSEcCtD
Fluphenazine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000257	0.00139	CcSEcCtD
Fluphenazine—Headache—Topotecan—peripheral nervous system neoplasm	0.000256	0.00138	CcSEcCtD
Fluphenazine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000255	0.00138	CcSEcCtD
Fluphenazine—CYP2E1—cerebellum—peripheral nervous system neoplasm	0.000254	0.00355	CbGeAlD
Fluphenazine—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000254	0.00137	CcSEcCtD
Fluphenazine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000254	0.00137	CcSEcCtD
Fluphenazine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000254	0.00137	CcSEcCtD
Fluphenazine—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000253	0.00137	CcSEcCtD
Fluphenazine—Constipation—Vincristine—peripheral nervous system neoplasm	0.000253	0.00136	CcSEcCtD
Fluphenazine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000244	0.00132	CcSEcCtD
Fluphenazine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000244	0.00131	CcSEcCtD
Fluphenazine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000244	0.00131	CcSEcCtD
Fluphenazine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000243	0.00131	CcSEcCtD
Fluphenazine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000242	0.00131	CcSEcCtD
Fluphenazine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000241	0.0013	CcSEcCtD
Fluphenazine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000241	0.0013	CcSEcCtD
Fluphenazine—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.0013	CcSEcCtD
Fluphenazine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00024	0.00129	CcSEcCtD
Fluphenazine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000237	0.00128	CcSEcCtD
Fluphenazine—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000236	0.00127	CcSEcCtD
Fluphenazine—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000236	0.00127	CcSEcCtD
Fluphenazine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000234	0.00126	CcSEcCtD
Fluphenazine—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000234	0.00126	CcSEcCtD
Fluphenazine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000234	0.00126	CcSEcCtD
Fluphenazine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000233	0.00126	CcSEcCtD
Fluphenazine—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000233	0.00125	CcSEcCtD
Fluphenazine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000227	0.00123	CcSEcCtD
Fluphenazine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000226	0.00122	CcSEcCtD
Fluphenazine—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000224	0.00121	CcSEcCtD
Fluphenazine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000224	0.00121	CcSEcCtD
Fluphenazine—HTR2A—cerebellum—peripheral nervous system neoplasm	0.000221	0.00309	CbGeAlD
Fluphenazine—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000219	0.00118	CcSEcCtD
Fluphenazine—Nefazodone—ABCB1—peripheral nervous system neoplasm	0.000219	0.0997	CrCbGaD
Fluphenazine—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000218	0.00118	CcSEcCtD
Fluphenazine—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000218	0.00118	CcSEcCtD
Fluphenazine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000218	0.00117	CcSEcCtD
Fluphenazine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000217	0.00117	CcSEcCtD
Fluphenazine—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.00117	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000216	0.00116	CcSEcCtD
Fluphenazine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000214	0.00115	CcSEcCtD
Fluphenazine—Triflupromazine—ABCB1—peripheral nervous system neoplasm	0.000214	0.0972	CrCbGaD
Fluphenazine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000213	0.00115	CcSEcCtD
Fluphenazine—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000212	0.00114	CcSEcCtD
Fluphenazine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000211	0.00114	CcSEcCtD
Fluphenazine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000208	0.00112	CcSEcCtD
Fluphenazine—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.00112	CcSEcCtD
Fluphenazine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000207	0.00111	CcSEcCtD
Fluphenazine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000205	0.0011	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.00109	CcSEcCtD
Fluphenazine—Trazodone—ABCB1—peripheral nervous system neoplasm	0.000203	0.0923	CrCbGaD
Fluphenazine—CYP2D6—cerebellum—peripheral nervous system neoplasm	0.000201	0.00281	CbGeAlD
Fluphenazine—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.00108	CcSEcCtD
Fluphenazine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000197	0.00106	CcSEcCtD
Fluphenazine—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000196	0.00106	CcSEcCtD
Fluphenazine—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.00106	CcSEcCtD
Fluphenazine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.00105	CcSEcCtD
Fluphenazine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000193	0.00104	CcSEcCtD
Fluphenazine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000192	0.00104	CcSEcCtD
Fluphenazine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00019	0.00103	CcSEcCtD
Fluphenazine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000189	0.00102	CcSEcCtD
Fluphenazine—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000186	0.001	CcSEcCtD
Fluphenazine—Headache—Vincristine—peripheral nervous system neoplasm	0.000185	0.000999	CcSEcCtD
Fluphenazine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000182	0.000983	CcSEcCtD
Fluphenazine—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.00098	CcSEcCtD
Fluphenazine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000176	0.000952	CcSEcCtD
Fluphenazine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000176	0.000947	CcSEcCtD
Fluphenazine—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000929	CcSEcCtD
Fluphenazine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000169	0.000914	CcSEcCtD
Fluphenazine—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000165	0.000887	CcSEcCtD
Fluphenazine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000853	CcSEcCtD
Fluphenazine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000155	0.000837	CcSEcCtD
Fluphenazine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000836	CcSEcCtD
Fluphenazine—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000821	CcSEcCtD
Fluphenazine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000815	CcSEcCtD
Fluphenazine—Headache—Etoposide—peripheral nervous system neoplasm	0.00015	0.000809	CcSEcCtD
Fluphenazine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000794	CcSEcCtD
Fluphenazine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000789	CcSEcCtD
Fluphenazine—ABCB1—cerebellum—peripheral nervous system neoplasm	0.000145	0.00202	CbGeAlD
Fluphenazine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000774	CcSEcCtD
Fluphenazine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000142	0.000767	CcSEcCtD
Fluphenazine—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000766	CcSEcCtD
Fluphenazine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000754	CcSEcCtD
Fluphenazine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000739	CcSEcCtD
Fluphenazine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000735	CcSEcCtD
Fluphenazine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000724	CcSEcCtD
Fluphenazine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000709	CcSEcCtD
Fluphenazine—Trifluoperazine—ABCB1—peripheral nervous system neoplasm	0.000131	0.0597	CrCbGaD
Fluphenazine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000707	CcSEcCtD
Fluphenazine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000703	CcSEcCtD
Fluphenazine—Quetiapine—ABCB1—peripheral nervous system neoplasm	0.000127	0.0579	CrCbGaD
Fluphenazine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000683	CcSEcCtD
Fluphenazine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000677	CcSEcCtD
Fluphenazine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.00067	CcSEcCtD
Fluphenazine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000654	CcSEcCtD
Fluphenazine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000651	CcSEcCtD
Fluphenazine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000646	CcSEcCtD
Fluphenazine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000644	CcSEcCtD
Fluphenazine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000629	CcSEcCtD
Fluphenazine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000626	CcSEcCtD
Fluphenazine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000619	CcSEcCtD
Fluphenazine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000597	CcSEcCtD
Fluphenazine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000596	CcSEcCtD
Fluphenazine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000582	CcSEcCtD
Fluphenazine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000575	CcSEcCtD
Fluphenazine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000573	CcSEcCtD
Fluphenazine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000572	CcSEcCtD
Fluphenazine—Chlorpromazine—ABCB1—peripheral nervous system neoplasm	0.000103	0.0469	CrCbGaD
Fluphenazine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	9.89e-05	0.000533	CcSEcCtD
Fluphenazine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	9.87e-05	0.000532	CcSEcCtD
Fluphenazine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	9.82e-05	0.00053	CcSEcCtD
Fluphenazine—Pruritus—Epirubicin—peripheral nervous system neoplasm	9.5e-05	0.000512	CcSEcCtD
Fluphenazine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	9.15e-05	0.000494	CcSEcCtD
Fluphenazine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	8.79e-05	0.000474	CcSEcCtD
Fluphenazine—Headache—Epirubicin—peripheral nervous system neoplasm	8.41e-05	0.000454	CcSEcCtD
Fluphenazine—Nausea—Epirubicin—peripheral nervous system neoplasm	7.98e-05	0.00043	CcSEcCtD
Fluphenazine—Headache—Doxorubicin—peripheral nervous system neoplasm	7.78e-05	0.00042	CcSEcCtD
Fluphenazine—Nausea—Doxorubicin—peripheral nervous system neoplasm	7.38e-05	0.000398	CcSEcCtD
Fluphenazine—ADRA2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.47e-05	0.000161	CbGpPWpGaD
Fluphenazine—CALM2—Hemostasis—NRAS—peripheral nervous system neoplasm	1.47e-05	0.00016	CbGpPWpGaD
Fluphenazine—CALM1—Hemostasis—NRAS—peripheral nervous system neoplasm	1.47e-05	0.00016	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.46e-05	0.000159	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	1.46e-05	0.000159	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.45e-05	0.000158	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—ABCB1—peripheral nervous system neoplasm	1.45e-05	0.000158	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by Wnt—AKT1—peripheral nervous system neoplasm	1.43e-05	0.000156	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—GNAS—peripheral nervous system neoplasm	1.43e-05	0.000156	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—GNAS—peripheral nervous system neoplasm	1.43e-05	0.000156	CbGpPWpGaD
Fluphenazine—DRD1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.42e-05	0.000154	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.41e-05	0.000154	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.4e-05	0.000153	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.4e-05	0.000153	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.4e-05	0.000153	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.4e-05	0.000153	CbGpPWpGaD
Fluphenazine—DRD3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.4e-05	0.000152	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.39e-05	0.000151	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.39e-05	0.000151	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by Wnt—AKT1—peripheral nervous system neoplasm	1.38e-05	0.000151	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by Wnt—AKT1—peripheral nervous system neoplasm	1.38e-05	0.000151	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	1.38e-05	0.00015	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	1.37e-05	0.00015	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.37e-05	0.000149	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	1.37e-05	0.000149	CbGpPWpGaD
Fluphenazine—CALM3—Innate Immune System—NRAS—peripheral nervous system neoplasm	1.37e-05	0.000149	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.37e-05	0.000149	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.37e-05	0.000149	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.35e-05	0.000147	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.35e-05	0.000147	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—PTPN11—peripheral nervous system neoplasm	1.33e-05	0.000144	CbGpPWpGaD
Fluphenazine—CALM2—Innate Immune System—NRAS—peripheral nervous system neoplasm	1.32e-05	0.000144	CbGpPWpGaD
Fluphenazine—CALM1—Innate Immune System—NRAS—peripheral nervous system neoplasm	1.32e-05	0.000144	CbGpPWpGaD
Fluphenazine—CALM3—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	1.32e-05	0.000143	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.31e-05	0.000143	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.3e-05	0.000142	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.3e-05	0.000142	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	1.29e-05	0.000141	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—PTPN11—peripheral nervous system neoplasm	1.28e-05	0.00014	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—PTPN11—peripheral nervous system neoplasm	1.28e-05	0.00014	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.28e-05	0.000139	CbGpPWpGaD
Fluphenazine—ADRA2A—Hemostasis—TP53—peripheral nervous system neoplasm	1.28e-05	0.000139	CbGpPWpGaD
Fluphenazine—CALM2—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	1.27e-05	0.000139	CbGpPWpGaD
Fluphenazine—CALM1—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	1.27e-05	0.000139	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.23e-05	0.000134	CbGpPWpGaD
Fluphenazine—CALM3—Disease—PTPN11—peripheral nervous system neoplasm	1.22e-05	0.000133	CbGpPWpGaD
Fluphenazine—ADRA2A—Hemostasis—HRAS—peripheral nervous system neoplasm	1.22e-05	0.000133	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.22e-05	0.000133	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.21e-05	0.000132	CbGpPWpGaD
Fluphenazine—HTR6—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.2e-05	0.000131	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.2e-05	0.00013	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.19e-05	0.00013	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.19e-05	0.00013	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.19e-05	0.00013	CbGpPWpGaD
Fluphenazine—CALM2—Disease—PTPN11—peripheral nervous system neoplasm	1.18e-05	0.000129	CbGpPWpGaD
Fluphenazine—CALM1—Disease—PTPN11—peripheral nervous system neoplasm	1.18e-05	0.000129	CbGpPWpGaD
Fluphenazine—HTR6—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.17e-05	0.000127	CbGpPWpGaD
Fluphenazine—CALM3—Hemostasis—TP53—peripheral nervous system neoplasm	1.16e-05	0.000127	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	1.16e-05	0.000127	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.16e-05	0.000126	CbGpPWpGaD
Fluphenazine—CALM2—Hemostasis—TP53—peripheral nervous system neoplasm	1.13e-05	0.000123	CbGpPWpGaD
Fluphenazine—CALM1—Hemostasis—TP53—peripheral nervous system neoplasm	1.13e-05	0.000123	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	1.12e-05	0.000122	CbGpPWpGaD
Fluphenazine—CALM3—Hemostasis—HRAS—peripheral nervous system neoplasm	1.11e-05	0.000121	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.11e-05	0.000121	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.1e-05	0.00012	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	1.09e-05	0.000119	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.08e-05	0.000118	CbGpPWpGaD
Fluphenazine—ADRA2A—Hemostasis—AKT1—peripheral nervous system neoplasm	1.08e-05	0.000117	CbGpPWpGaD
Fluphenazine—CALM2—Hemostasis—HRAS—peripheral nervous system neoplasm	1.08e-05	0.000117	CbGpPWpGaD
Fluphenazine—CALM1—Hemostasis—HRAS—peripheral nervous system neoplasm	1.08e-05	0.000117	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.07e-05	0.000116	CbGpPWpGaD
Fluphenazine—HTR6—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.06e-05	0.000116	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	1.05e-05	0.000115	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.05e-05	0.000115	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.05e-05	0.000114	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.05e-05	0.000114	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—ERBB2—peripheral nervous system neoplasm	1.05e-05	0.000114	CbGpPWpGaD
Fluphenazine—DRD1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.04e-05	0.000113	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	1.03e-05	0.000113	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.03e-05	0.000113	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.03e-05	0.000112	CbGpPWpGaD
Fluphenazine—DRD3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.02e-05	0.000111	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—ERBB2—peripheral nervous system neoplasm	1.01e-05	0.00011	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—ERBB2—peripheral nervous system neoplasm	1.01e-05	0.00011	CbGpPWpGaD
Fluphenazine—DRD1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.01e-05	0.00011	CbGpPWpGaD
Fluphenazine—CALM3—Innate Immune System—HRAS—peripheral nervous system neoplasm	1e-05	0.000109	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	9.98e-06	0.000109	CbGpPWpGaD
Fluphenazine—DRD3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	9.94e-06	0.000108	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	9.84e-06	0.000107	CbGpPWpGaD
Fluphenazine—CALM3—Hemostasis—AKT1—peripheral nervous system neoplasm	9.83e-06	0.000107	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.72e-06	0.000106	CbGpPWpGaD
Fluphenazine—CALM2—Innate Immune System—HRAS—peripheral nervous system neoplasm	9.69e-06	0.000106	CbGpPWpGaD
Fluphenazine—CALM1—Innate Immune System—HRAS—peripheral nervous system neoplasm	9.69e-06	0.000106	CbGpPWpGaD
Fluphenazine—CALM3—Disease—ERBB2—peripheral nervous system neoplasm	9.68e-06	0.000105	CbGpPWpGaD
Fluphenazine—CALM3—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	9.62e-06	0.000105	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	9.57e-06	0.000104	CbGpPWpGaD
Fluphenazine—CALM2—Hemostasis—AKT1—peripheral nervous system neoplasm	9.51e-06	0.000104	CbGpPWpGaD
Fluphenazine—CALM1—Hemostasis—AKT1—peripheral nervous system neoplasm	9.51e-06	0.000104	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.45e-06	0.000103	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.4e-06	0.000102	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	9.4e-06	0.000102	CbGpPWpGaD
Fluphenazine—CALM1—Disease—ERBB2—peripheral nervous system neoplasm	9.36e-06	0.000102	CbGpPWpGaD
Fluphenazine—CALM2—Disease—ERBB2—peripheral nervous system neoplasm	9.36e-06	0.000102	CbGpPWpGaD
Fluphenazine—CALM2—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	9.31e-06	0.000101	CbGpPWpGaD
Fluphenazine—CALM1—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	9.31e-06	0.000101	CbGpPWpGaD
Fluphenazine—DRD1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	9.14e-06	9.96e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.05e-06	9.86e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	9.02e-06	9.83e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	8.93e-06	9.73e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.91e-06	9.7e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.86e-06	9.65e-05	CbGpPWpGaD
Fluphenazine—CALM3—Innate Immune System—AKT1—peripheral nervous system neoplasm	8.85e-06	9.64e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	8.76e-06	9.54e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.73e-06	9.51e-05	CbGpPWpGaD
Fluphenazine—HTR1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.66e-06	9.43e-05	CbGpPWpGaD
Fluphenazine—HTR2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.62e-06	9.38e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.58e-06	9.35e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.58e-06	9.34e-05	CbGpPWpGaD
Fluphenazine—CALM1—Innate Immune System—AKT1—peripheral nervous system neoplasm	8.56e-06	9.32e-05	CbGpPWpGaD
Fluphenazine—CALM2—Innate Immune System—AKT1—peripheral nervous system neoplasm	8.56e-06	9.32e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.54e-06	9.3e-05	CbGpPWpGaD
Fluphenazine—CALM3—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	8.5e-06	9.25e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.45e-06	9.2e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.45e-06	9.2e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	8.36e-06	9.11e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.3e-06	9.04e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.3e-06	9.04e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.3e-06	9.04e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	8.25e-06	8.99e-05	CbGpPWpGaD
Fluphenazine—CALM1—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	8.22e-06	8.95e-05	CbGpPWpGaD
Fluphenazine—CALM2—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	8.22e-06	8.95e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.17e-06	8.89e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.15e-06	8.88e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—NRAS—peripheral nervous system neoplasm	7.98e-06	8.69e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.86e-06	8.57e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.82e-06	8.52e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.82e-06	8.52e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.79e-06	8.48e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—NRAS—peripheral nervous system neoplasm	7.72e-06	8.4e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—NRAS—peripheral nervous system neoplasm	7.72e-06	8.4e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.69e-06	8.38e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.69e-06	8.37e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.68e-06	8.36e-05	CbGpPWpGaD
Fluphenazine—DRD2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.6e-06	8.28e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.53e-06	8.21e-05	CbGpPWpGaD
Fluphenazine—HTR2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.48e-06	8.15e-05	CbGpPWpGaD
Fluphenazine—HRH1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.46e-06	8.13e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.43e-06	8.09e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.43e-06	8.09e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.41e-06	8.07e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.4e-06	8.06e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—NRAS—peripheral nervous system neoplasm	7.36e-06	8.02e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.19e-06	7.83e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.15e-06	7.79e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—NRAS—peripheral nervous system neoplasm	7.12e-06	7.76e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—NRAS—peripheral nervous system neoplasm	7.12e-06	7.76e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.11e-06	7.74e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7e-06	7.62e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.9e-06	7.52e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—MYC—peripheral nervous system neoplasm	6.86e-06	7.47e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.81e-06	7.41e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.79e-06	7.4e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.78e-06	7.38e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.78e-06	7.38e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.74e-06	7.34e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.7e-06	7.3e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.66e-06	7.26e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—MYC—peripheral nervous system neoplasm	6.64e-06	7.23e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—MYC—peripheral nervous system neoplasm	6.64e-06	7.23e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.56e-06	7.14e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.56e-06	7.14e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.4e-06	6.97e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.39e-06	6.96e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.31e-06	6.88e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.31e-06	6.88e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.28e-06	6.84e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.21e-06	6.77e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.2e-06	6.75e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.18e-06	6.73e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.18e-06	6.73e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.18e-06	6.73e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.15e-06	6.7e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.12e-06	6.66e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.04e-06	6.58e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.95e-06	6.48e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.95e-06	6.48e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.88e-06	6.41e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—HRAS—peripheral nervous system neoplasm	5.84e-06	6.36e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.79e-06	6.3e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.77e-06	6.29e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.65e-06	6.16e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—HRAS—peripheral nervous system neoplasm	5.65e-06	6.15e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—HRAS—peripheral nervous system neoplasm	5.65e-06	6.15e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.64e-06	6.14e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.5e-06	5.99e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.47e-06	5.96e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.46e-06	5.94e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.46e-06	5.94e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.4e-06	5.88e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—HRAS—peripheral nervous system neoplasm	5.39e-06	5.87e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.33e-06	5.81e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.26e-06	5.73e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.26e-06	5.73e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.23e-06	5.7e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—HRAS—peripheral nervous system neoplasm	5.21e-06	5.68e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—HRAS—peripheral nervous system neoplasm	5.21e-06	5.68e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.16e-06	5.62e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—AKT1—peripheral nervous system neoplasm	5.15e-06	5.61e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.99e-06	5.43e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.99e-06	5.43e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—AKT1—peripheral nervous system neoplasm	4.98e-06	5.43e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—AKT1—peripheral nervous system neoplasm	4.98e-06	5.43e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.83e-06	5.26e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.8e-06	5.23e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—AKT1—peripheral nervous system neoplasm	4.76e-06	5.18e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.75e-06	5.18e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.74e-06	5.17e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.65e-06	5.06e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.65e-06	5.06e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.65e-06	5.06e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.62e-06	5.03e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.62e-06	5.03e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—AKT1—peripheral nervous system neoplasm	4.6e-06	5.01e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—AKT1—peripheral nervous system neoplasm	4.6e-06	5.01e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.55e-06	4.95e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.54e-06	4.94e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—AKT1—peripheral nervous system neoplasm	4.37e-06	4.76e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.32e-06	4.71e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.14e-06	4.5e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.08e-06	4.44e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.01e-06	4.37e-05	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—AKT1—peripheral nervous system neoplasm	4.01e-06	4.37e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4e-06	4.36e-05	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—AKT1—peripheral nervous system neoplasm	3.98e-06	4.34e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.95e-06	4.3e-05	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—AKT1—peripheral nervous system neoplasm	3.85e-06	4.2e-05	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—AKT1—peripheral nervous system neoplasm	3.85e-06	4.2e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.82e-06	4.16e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.82e-06	4.16e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.77e-06	4.11e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.65e-06	3.98e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.65e-06	3.98e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.65e-06	3.98e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.33e-06	3.63e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.22e-06	3.51e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.22e-06	3.51e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	3.02e-06	3.29e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	2.85e-06	3.1e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	2.41e-06	2.63e-05	CbGpPWpGaD
